AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16393718 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 948
Study 16393718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 948
Study 12869077 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 30
Study 12869077 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab with concomitant antimetabolite agents
Number of subjects: 30
Study 10586170 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (1 to 2 RDA of elemental zinc 5 to 7 times per week)
Number of subjects: 7
Study 10586170 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (2 to 4 RDA daily for 2 weeks)
Number of subjects: 7
Study 8725013 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08 mm RGP lens
Number of subjects: 17
Study 8725013 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12 mm RGP lens
Number of subjects: 17
Study 8725013 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.16 mm RGP lens
Number of subjects: 17
Study 8725013 — intervention group
Group type: COMPARATOR
Intervention: Hydrogel control lens
Number of subjects: 17
Study 2067197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprophane membrane
Number of subjects: 8
Study 2067197 — intervention group
Group type: COMPARATOR
Intervention: Polymethylmethacrylate (PMMA) membrane
Number of subjects: 8
Study 6840172 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 mg with food (3566 kJ)
Number of subjects: 12
Study 6840172 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 mg with dihydralazine 25 mg
Number of subjects: 12
Study 6840172 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 mg with phenobarbitone 100 mg daily (1 week pretreatment)
Number of subjects: 12
Study 6840172 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate 10 mg with prazosin 1 mg
Number of subjects: 12
Study 31161850 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 mg/0.1 ml CTM gel
Number of subjects: 19
Study 31161850 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.88 mg/0.1 ml CTM
Number of subjects: 19
Study 31161850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 30226112 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for collaborative implementation planning (Community Engagement and Planning, CEP)
Number of subjects: 658
Study 30226112 — intervention group
Group type: COMPARATOR
Intervention: Technical support (Resources for Services, RS)
Number of subjects: 658
Study 29056437 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention providing reproductive health information
Number of subjects: 100
Study 29056437 — intervention group
Group type: COMPARATOR
Intervention: Standardized discharge instructions (Control)
Number of subjects: 100
Study 26019245 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (600 mg/d) plus cholecalciferol (200 IU/d) supplementation
Number of subjects: 56
Study 26019245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 25222307 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza A(H1N1)pdm09 vaccine (15 µg)
Number of subjects: 583
Study 25222307 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza A(H1N1)pdm09 vaccine (30 µg)
Number of subjects: 583
Study 25222307 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 583
Study 22706733 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 190
Study 22706733 — intervention group
Group type: COMPARATOR
Intervention: No mechanical bowel preparation (no MBP)
Number of subjects: 190
Study 19305235 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention (self-monitored physical activity using a pedometer and step calendar, 2 behavioral counseling and goal-setting sessions)
Number of subjects: 110
Study 19305235 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 110
Study 16697832 — intervention group
Group type: EXPERIMENTAL
Intervention: Central physician reviewers
Number of subjects: 36
Study 16697832 — intervention group
Group type: COMPARATOR
Intervention: Local physician reviewers
Number of subjects: 36
Study 15477371 — intervention group
Group type: EXPERIMENTAL
Intervention: T gel 100 mg/d
Number of subjects: 406
Study 15477371 — intervention group
Group type: COMPARATOR
Intervention: T gel 50 mg/d
Number of subjects: 406
Study 15477371 — intervention group
Group type: COMPARATOR
Intervention: T patch
Number of subjects: 406
Study 15477371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study 11245646 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 430
Study 11245646 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 430
Study 11245646 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD (in patients with low left ventricular ejection fraction <35%)
Number of subjects: 430
Study 11245646 — intervention group
Group type: COMPARATOR
Intervention: ICD and Amiodarone (alternative extrapolations)
Number of subjects: 430
Study 9192195 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin (soluble)
Number of subjects: 9
Study 9192195 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar beet fibre (partly soluble)
Number of subjects: 9
Study 9192195 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 9
Study 7943065 — intervention group
Group type: EXPERIMENTAL
Intervention: Blunt expansion
Number of subjects: 286
Study 7943065 — intervention group
Group type: COMPARATOR
Intervention: Sharp expansion
Number of subjects: 286
Study 3280640 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 million units of intravenous streptokinase
Number of subjects: 368
Study 3280640 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 368
Study 30738244 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 999
Study 30738244 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 999
Study 30738244 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP ≥10 mg/L
Number of subjects: 999
Study 30738244 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP modeled as a continuous log-transformed variable
Number of subjects: 999
Study 28617765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 100
Study 28617765 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional therapy)
Number of subjects: 100
Study 25180530 — intervention group
Group type: EXPERIMENTAL
Intervention: Home hand-arm bimanual intensive therapy (H-HABIT), 90 hours provided by trained caregivers
Number of subjects: 11
Study 23331333 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) treatment for an average of 4.8 months
Number of subjects: 58
Study 23331333 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment for an average of 4.4 months
Number of subjects: 58
Study 20349856 — intervention group
Group type: EXPERIMENTAL
Intervention: Topography-guided PRK
Number of subjects: 40
Study 20349856 — intervention group
Group type: COMPARATOR
Intervention: Wavefront-optimized PRK
Number of subjects: 40
Study 18242858 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure in vivo treatment (EXP)
Number of subjects: 85
Study 18242858 — intervention group
Group type: COMPARATOR
Intervention: Operant graded activity (GA)
Number of subjects: 85
Study 18242858 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (EXP and GA)
Number of subjects: 85
Study 16573817 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative expiratory pressure (NEP) -5 cmH2O in supine position
Number of subjects: 55
Study 16573817 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative expiratory pressure (NEP) -5 cmH2O in seated position
Number of subjects: 55
Study 16573817 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative expiratory pressure (NEP) -7 cmH2O
Number of subjects: 55
Study 15101023 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 61
Study 15101023 — intervention group
Group type: COMPARATOR
Intervention: NTG
Number of subjects: 61
Study 11779610 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiodol
Number of subjects: 34
Study 11779610 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (no treatment)
Number of subjects: 34
Study 9751000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine cue sessions
Number of subjects: 69
Study 9751000 — intervention group
Group type: COMPARATOR
Intervention: Non-drug events
Number of subjects: 69
Study 7545059 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP)
Number of subjects: 10
Study 7545059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2528862 — intervention group
Group type: EXPERIMENTAL
Intervention: Merck vaccine
Number of subjects: 0
Study 2528862 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteur vaccine
Number of subjects: 0
Study 2528862 — intervention group
Group type: COMPARATOR
Intervention: CLB vaccine
Number of subjects: 0
Study 2528862 — intervention group
Group type: COMPARATOR
Intervention: Korean vaccine
Number of subjects: 0
Study 29956648 — intervention group
Group type: EXPERIMENTAL
Intervention: New N-acetylcysteine 2% oral solution
Number of subjects: 46
Study 29956648 — intervention group
Group type: COMPARATOR
Intervention: Reference N-acetylcysteine 2% oral solution
Number of subjects: 46
Study 30711316 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 0
Study 30711316 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28257217 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak LC Bond (G1)
Number of subjects: 90
Study 28257217 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (G2)
Number of subjects: 90
Study 28257217 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond with prior selective acid etching (G3)
Number of subjects: 90
Study 26241460 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 42
Study 26241460 — intervention group
Group type: COMPARATOR
Intervention: Placebo Device (PD)
Number of subjects: 42
Study 26241460 — intervention group
Group type: EXPERIMENTAL
Intervention: MAD
Number of subjects: 42
Study 26241460 — intervention group
Group type: COMPARATOR
Intervention: PD
Number of subjects: 42
Study 23998148 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrangement using adhesive paper teeth
Number of subjects: 123
Study 23998148 — intervention group
Group type: COMPARATOR
Intervention: Traditional standard care selection and arrangement of anterior teeth
Number of subjects: 123
Study 22122821 — intervention group
Group type: EXPERIMENTAL
Intervention: Xeldrin®20 (test product)
Number of subjects: 24
Study 22122821 — intervention group
Group type: COMPARATOR
Intervention: Losec®20 (reference product)
Number of subjects: 24
Study 19369174 — intervention group
Group type: EXPERIMENTAL
Intervention: RotaTeq (pentavalent rotavirus vaccine), three oral doses
Number of subjects: 189
Study 19369174 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 189
Study 15148646 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior levatorplasty
Number of subjects: 54
Study 15148646 — intervention group
Group type: COMPARATOR
Intervention: Internal sphincterotomy
Number of subjects: 54
Study 11208686 — intervention group
Group type: EXPERIMENTAL
Intervention: Genistein (10 to 300 nmol/min for 6 minutes)
Number of subjects: 15
Study 11208686 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta-estradiol (equimolar concentrations)
Number of subjects: 15
Study 11208686 — intervention group
Group type: EXPERIMENTAL
Intervention: Genistein
Number of subjects: 15
Study 11208686 — intervention group
Group type: COMPARATOR
Intervention: N:(G)‐monomethyl‐L‐arginine (NO synthase inhibitor)
Number of subjects: 15
Study 9409357 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I (0.10 mg/kg/day)
Number of subjects: 266
Study 9409357 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I (0.05 mg/kg/day)
Number of subjects: 266
Study 9409357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study 8108538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular steroids
Number of subjects: 111
Study 8108538 — intervention group
Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 111
Study 3653529 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg p.o. 3 times/day for 4 days and 10 mg 1.5 h before investigation
Number of subjects: 0
Study 3653529 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0
Study 31797532 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month duration of dual antiplatelet therapy (DAPT) after elective drug-coated balloon angioplasty
Number of subjects: 303
Study 29954759 — intervention group
Group type: EXPERIMENTAL
Intervention: Marinated beef
Number of subjects: 0
Study 29954759 — intervention group
Group type: COMPARATOR
Intervention: Non-marinated beef
Number of subjects: 0
Study 29325367 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise combined with resistance training for 12 weeks
Number of subjects: 73
Study 29325367 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical treatment and health education
Number of subjects: 73
Study 26257511 — intervention group
Group type: EXPERIMENTAL
Intervention: HCP1004 (naproxen 500 mg and esomeprazole strontium 20 mg)
Number of subjects: 70
Study 26257511 — intervention group
Group type: COMPARATOR
Intervention: VIMOVO® (naproxen 500 mg and esomeprazole magnesium 20 mg)
Number of subjects: 70
Study 26257511 — intervention group
Group type: COMPARATOR
Intervention: Comparison of HCP1004 to VIMOVO®
Number of subjects: 70
Study 23392414 — intervention group
Group type: EXPERIMENTAL
Intervention: Xclose Tissue Repair System (Anulex Technologies, Minnetonka, MN) for anular repair
Number of subjects: 750
Study 23392414 — intervention group
Group type: COMPARATOR
Intervention: Discectomy without anular repair
Number of subjects: 750
Study 23392414 — intervention group
Group type: EXPERIMENTAL
Intervention: Xclose Tissue Repair System
Number of subjects: 750
Study 23392414 — intervention group
Group type: EXPERIMENTAL
Intervention: Xclose Tissue Repair System and Discectomy without anular repair
Number of subjects: 750
Study 20491152 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole Group (IG) - wore MedReflex shoe insoles during everyday life and training sessions
Number of subjects: 28
Study 20491152 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Group (TG) - completed the same training program without insoles
Number of subjects: 28
Study 20491152 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - no exercise
Number of subjects: 28
Study 18181880 — intervention group
Group type: EXPERIMENTAL
Intervention: Inner speech
Number of subjects: 45
Study 18181880 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual coding
Number of subjects: 45
Study 18181880 — intervention group
Group type: COMPARATOR
Intervention: Control stimuli
Number of subjects: 45
Study 16644437 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise echocardiography with HCU device (EchoCG-HCU)
Number of subjects: 58
Study 16644437 — intervention group
Group type: COMPARATOR
Intervention: Exercise electrocardiography (ECG)
Number of subjects: 58
Study 12673180 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise (handgrip at 75% of maximal strength for up to 5 minutes) in HCM patients
Number of subjects: 46
Study 12673180 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no intervention)
Number of subjects: 46
Study 12673180 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise (handgrip at 75% of maximal strength for up to 5 minutes) in obstructive HCM patients
Number of subjects: 46
Study 12673180 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise (handgrip at 75% of maximal strength for up to 5 minutes) in nonobstructive HCM patients
Number of subjects: 46
Study 11099371 — intervention group
Group type: EXPERIMENTAL
Intervention: Siberian ginseng (ES) 1,200 mg/day
Number of subjects: 9
Study 11099371 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 9
Study 11099371 — intervention group
Group type: EXPERIMENTAL
Intervention: Siberian ginseng (ES)
Number of subjects: 9
Study 8615502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild intraoperative hypothermia
Number of subjects: 10
Study 8615502 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative core temperature
Number of subjects: 10
Study 8615502 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro temperature manipulations
Number of subjects: 10
Study 8615502 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative hypothermia
Number of subjects: 10
Study 1727915 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate disodium (APD) 60 mg as a single 24-hour infusion
Number of subjects: 65
Study 1727915 — intervention group
Group type: COMPARATOR
Intervention: Etidronate disodium (EHDP) 7.5 mg/kg given as a 2-hour infusion daily for 3 days
Number of subjects: 65
Study 6379455 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 479
Study 6379455 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 479
Study 29603286 — intervention group
Group type: EXPERIMENTAL
Intervention: Lettuce (300 g with 30 mL mayonnaise)
Number of subjects: 15
Study 29603286 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb (300 g with 60 mL lactose free cream)
Number of subjects: 15
Study 29603286 — intervention group
Group type: COMPARATOR
Intervention: Bread (2 slices with 10 g butter)
Number of subjects: 15
Study 26780969 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation for 12 months
Number of subjects: 45
Study 26780969 — intervention group
Group type: COMPARATOR
Intervention: Control group without supplementation
Number of subjects: 45
Study 24428461 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive quitline support in combination with tailored supplementary materials
Number of subjects: 512
Study 24428461 — intervention group
Group type: COMPARATOR
Intervention: Standard self-help brochure
Number of subjects: 512
Study 24428461 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive quitline support
Number of subjects: 512
Study 22905896 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 89
Study 22905896 — intervention group
Group type: COMPARATOR
Intervention: spirit‐only MI (SOMI)
Number of subjects: 89
Study 22905896 — intervention group
Group type: COMPARATOR
Intervention: self‐change (SC)
Number of subjects: 89
Study 20446817 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: output voltage increased from 25% to 35% to 45% with 800 shocks per voltage
Number of subjects: 62
Study 20446817 — intervention group
Group type: COMPARATOR
Intervention: Group B: constant output voltage of 35%
Number of subjects: 62
Study 20446817 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: output voltage decreased from 45% to 35% to 25%
Number of subjects: 62
Study 18018469 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily for six months
Number of subjects: 40
Study 18018469 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 16122593 — intervention group
Group type: EXPERIMENTAL
Intervention: Centric splint
Number of subjects: 74
Study 16122593 — intervention group
Group type: COMPARATOR
Intervention: Distraction splint
Number of subjects: 74
Study 12373624 — intervention group
Group type: EXPERIMENTAL
Intervention: High phenol olive oil (70 grams per day)
Number of subjects: 25
Study 12373624 — intervention group
Group type: COMPARATOR
Intervention: Low phenol olive oil (70 grams per day)
Number of subjects: 25
Study 11257952 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0625% bupivacaine
Number of subjects: 60
Study 11257952 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 60
Study 11257952 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 60
Study 9247511 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 244
Study 9247511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 8102430 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 2.7 g daily for 6 weeks
Number of subjects: 16
Study 8102430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 3770031 — intervention group
Group type: EXPERIMENTAL
Intervention: Carminomycin (CMM) 20 mg/m2
Number of subjects: 64
Study 3770031 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (DOX) 75 mg/m2
Number of subjects: 64
Study 29978276 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES) guidance for BoNT A injection
Number of subjects: 40
Study 29978276 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (USG) guidance for BoNT A injection
Number of subjects: 40
Study 29852286 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid training system (HTS)
Number of subjects: 42
Study 29852286 — intervention group
Group type: COMPARATOR
Intervention: Isokinetic dynamometer (control)
Number of subjects: 42
Study 26762150 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Decision Aid (PDA)
Number of subjects: 225
Study 26762150 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 225
Study 25701140 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological intervention (250 μg of recombinant hCG)
Number of subjects: 16
Study 25701140 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical intervention (aspiration of dominant and subordinate follicles ≥10 mm)
Number of subjects: 16
Study 25701140 — intervention group
Group type: COMPARATOR
Intervention: Control group (150 IU/day of recombinant follicle-stimulating hormone starting on menstrual cycle day 3)
Number of subjects: 16
Study 23877348 — intervention group
Group type: EXPERIMENTAL
Intervention: lactulose plus rifaximin 1,200 mg/day
Number of subjects: 120